MyAverix Finance
US · Healthcare
Herborium Group Inc (HBRM)
Drug Manufacturers - Specialty & Generic
Herborium Group Inc (HBRM) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HBRM
Herborium Group Inc (HBRM) — FAQ
What is HBRM's P/E ratio?
The price-to-earnings (P/E) ratio for Herborium Group Inc (HBRM) is 18.00 (data as of 2026-05-23).
Does Herborium Group Inc pay a dividend?
Dividend yield is not available in the current snapshot for Herborium Group Inc (HBRM). Check the MyAverix Finance app for the latest dividend data.
What sector is Herborium Group Inc in?
Herborium Group Inc (HBRM) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is HBRM listed on?
HBRM is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.